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Objectives: The purpose of this study was to evaluate the reliability of carotid duplex ultrasound scanning performed by
nonaccredited vascular laboratories and to assess the clinical effect on patient management.
Methods: We retrospectively reviewed concordance of findings of carotid duplex ultrasound scanning between laboratories
accredited by the Intersocietal Commission for Accreditation of Vascular Laboratories and nonaccredited laboratories in
174 patients with asymptomatic disease referred to tertiary care community hospitals for surgical evaluation for carotid
endarterectomy (CEA) between January 2001 and December 2002, and evaluated changes in clinical management made
on the basis of repeat examinations.
Results: Concordant findings were noted in 171 of 348 arteries (49%), predominantly those with minimal or mild disease
(114 arteries; 67%). Discordant findings of no clinical significance were found in 54 arteries (16%). Clinically significant
discordant findings were noted in 123 arteries (35%) in 107 patients (61%). In 104 arteries (88 patients) stenosis was
overestimated by the nonaccredited laboratory secondary to technical error (19 arteries), use of B-mode imaging data
alone (36 arteries), and use of inappropriate velocity criteria (49 arteries). None of these patients underwent CEA.
Stenosis was significantly underestimated in 19 arteries (19 patients); all of these patients underwent uncomplicated
CEA.
Conclusions: Incorrect physician interpretation of data is the most common cause of error in carotid duplex ultrasound
scanning performed in nonaccredited vascular laboratories. Results of carotid duplex ultrasound scanning from
nonaccredited laboratories should be considered with extreme caution, and do not appear reliable in planning treatment
of obstructive disease. (J Vasc Surg 2004;39:366-71.)
The results of several multi-institution randomized tri-
als provide a compelling rationale for surgical treatment of
symptomatic and asymptomatic stenoses of the internal
carotid artery (ICA) in appropriate patients on the basis of
degree of stenosis.1-3 While the evidence supporting surgi-
cal therapy for occlusive disease of the ICA is largely based
on results obtained for treatment of angiographically con-
firmed stenoses, in modern clinical practice carotid duplex
ultrasound scanning is increasingly the sole preoperative
diagnostic study performed before carotid endarterectomy
(CEA) in many medical centers.4-6 Vascular surgeons have
come to rely increasingly on the results of carotid duplex
ultrasound scanning alone when making decisions regard-
ing surgical intervention to treat carotid artery occlusive
disease. The accuracy of carotid duplex ultrasound scan-
ning in assessment of the degree of ICA stenosis is approx-
imately 90% if performed with proper technique and inter-
preted by experienced clinicians with established and
validated criteria.7-9 However, the results of carotid duplex
ultrasound scanning are both operator-dependent and
technology-dependent.10 Furthermore, not all vascular
laboratories use identical criteria for determining degree of
stenosis.11-13 These discrepancies raise the possibility that
interlaboratory variability in the diagnosis of ICA stenosis
may have significant adverse effects on patient management
and surgical decision-making.
The Intersocietal Commission for Accreditation of
Vascular Laboratories (ICAVL) was established, in part, to
ensure that the diagnostic results obtained from accredited
vascular laboratories are both accurate and reproducible.14
The establishment of standards for testing protocols, uni-
form criteria for determining degree of stenosis, and train-
ing and ongoing education of those technologists and
physicians responsible for the studies serve to increase the
reliability of carotid duplex ultrasound scans from ICAVL-
accredited vascular laboratories. More than 1500 vascular
laboratories in the United States have been accredited by
ICAVL since 1990, but given the large number of carotid
duplex ultrasound scanning examinations performed each
year, a significant proportion clearly are done in nonaccred-
ited vascular laboratories. A report by Elmore et al15
showed poor concordance in terms of degree of stenosis
between their accredited vascular laboratory and studies
from outside vascular laboratories. In this study we report
our findings on the concordance of carotid duplex ultra-
sound scanning performed in ICAVL-accredited versus
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nonaccredited vascular laboratories and the clinical impli-
cations of these findings on patient management.
MATERIAL AND METHODS
Records for patients with asymptomatic disease re-
ferred for surgical evaluation for CEA between January
2001 and December 2002 on the basis of findings on
carotid duplex ultrasound scans from a nonaccredited vas-
cular laboratory were reviewed. Absolute velocity and ve-
locity ratio data (when included in the report) and inter-
pretation of the outside studies were recorded. Clinical
implications of each study were based on North American
Symptomatic Carotid Endarterectomy Trial (NASCET)
and Asymptomatic Carotid Atherosclerosis Study (ACAS)
criteria for the treatment of carotid artery stenosis. All
patients underwent repeat carotid duplex ultrasound scan-
ning in an ICAVL-accredited laboratory. All repeat studies
were performed by a registered vascular technologist. All
studies were done using standardized testing protocols,
with spectral Doppler velocity data and both longitudinal
and transverse imaging of the extracranial carotid and ver-
tebral arteries. Spectral Doppler velocity was obtained at an
angle of insonation of 60 degrees or less, with attempts to
be as close to 60 degrees as possible. Peak systolic velocity
(PSV) and end-diastolic velocity of the ICA and distal
common carotid artery, as well as the ICA-CCA PSV ratio,
were recorded. In addition, the presence and direction of
vertebral artery flow were recorded. Degree of stenosis was
determined with the NASCET/ACAS method, with the
diameter of the normal distal ICA serving as the reference,
and the velocity criteria used were laboratory-specific data
validated with internal quality assurance programs as man-
dated by the ICAVL (Table I). Patients whose treatment
plan was altered on the basis of results of repeated carotid
duplex scanning were noted. Data from any subsequent
correlating imaging studies or surgeries were also recorded.
RESULTS
One hundred seventy-four patients were referred for
surgical evaluation for CEA during the study. The interpre-
tation and final reports from outside vascular laboratories
were noted to contain no velocity data for 22 patients
(13%); 69 reports (40%) contained only PSV data, with no
end-diastolic velocity information; for 26 patients (15%)
the ICA-CCA ratio was not calculated correctly; and the
status of the vertebral arteries was not mentioned in 25
reports (14%). It was not possible to determine from the
vast majority of reports whether the study had been per-
formed by a registered vascular technologist, and the qual-
ifications and training of the interpreting physician were
not known.
Agreement as to severity of carotid artery stenosis was
found in 171 of 348 vessels (49%; Table II). One hundred
fourteen (67%) of these stenoses were in vessels with min-
imal or mild disease contralateral to a vessel with diagnosed
severe (60% diameter reduction) or critical (80% diam-
eter reduction) stenosis, 45 were in vessels with severe or
critical disease, and 12 were in totally occluded ICAs.
Discordant findings were noted in 177 vessels. In 54 cases
these discordant findings were minor, in vessels with min-
imal or mild disease, and not of any clinical significance.
Clinically significant discordant findings, sufficient to alter
patient management, were found in 123 arteries (35%) in
107 patients (61%).
In 104 vessels (88 patients) the study from a nonac-
credited vascular laboratory overestimated the degree of
stenosis, with a diagnosis of severe or critical disease; the
repeat carotid duplex ultrasound scans showed these lesions
to cause less than 60% diameter reduction (Table III). The
overestimation of the degree of stenosis was a result of
technical errors in velocity measurement in 19 arteries
(18%), estimation of the degree of stenosis based on B-
mode images and not velocity criteria in 36 arteries (35%),
and use of diagnostic criteria different from the NASCET/
Table III. Causes for inaccurate estimation of stenosis
(123 vessels)
Overestimation
(104 vessels)
Understimation
(19 vessels)
n % n %
Technical errors in velocity
measurement
19 18 5 26
Use of B-mode imaging
data only
36 35 7 37
Inappropriate velocity
criteria
49 47 7 37
Table I. Velocity criteria used to categorize stenosis
greater than 60% diameter reduction
PSV (cm/s) EDV (cm/s) ICA/CCA
Filis et al12 200 70 2.2
Moneta et al11 260/290 70/80 3.2/3.5
WBH* 250 90 3.5
PSV, Peak systolic velocity; EDV, end-diastolic velocity; ICA/CCA, internal
carotid artery to common carotid artery PSV ratio.
*Internally validated data from quality assurance program.
Table II. Concordance of interpretations between
ICAVL-accredited vascular laboratories and
nonaccredited vascular laboratories (174 patients)
n %
Agreement 171/348 vessels 49
Minimal/mild disease 114/171 vessels 67
Minor discordance 54/348 vessels 16
Significant discordance 123/348 vessels 35
107/174 patients 62
Stenosis overestimated 104/123 vessels 51
88 patients
Stenosis underestimated 19/123 vessels 11
19 patients
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ACAS method in 49 arteries (47%). None of these patients
underwent CEA. Two patients underwent follow-up mag-
netic resonance angiography (MRA), which confirmed the
ICAVL-accredited laboratory findings; the remainder of
patients continue to have no symptoms, and are scheduled
for noninvasive follow-up appropriate to their findings.
In 19 arteries (19 patients) disease severity was signifi-
cantly underestimated at the original duplex ultrasound
scanning examination (Table III). In these patients under-
estimation of degree of stenosis was a result of technical
error in velocity measurement in 5 vessels (26%), use of
B-mode image data alone to determine the degree of
stenosis in 7 vessels (37%), and applyication of non-
NASCET/ACAS criteria in 7 vessels (37%). MRA images
confirmed the ICAVL laboratory findings in 5 of these
patients, and all 19 patients underwent successful CEA
without complication, with confirmation of significant ca-
rotid artery atherosclerotic disease at surgery.
DISCUSSION
The benefits of CEA in patients with symptomatic
disease with greater than 50% arteriographically confirmed
stenosis of the ICA and in patients with asymptomatic
disease with greater than 60% stenosis are well-estab-
lished.1-3 Carotid angiography was accepted as the gold
standard for assessment of degree of stenosis in these stud-
ies. However, carotid angiography is an invasive diagnostic
procedure associated with 0.2% to 4% risk for serious com-
plications, including approximately 1% risk for stroke.1,2
Moreover, it has been estimated that carotid angiography
may be seven to ten times more costly than duplex ultra-
sound scanning for the preoperative evaluation of carotid
artery occlusive disease.7 In the past two decades carotid
duplex ultrasound scanning increasingly has become the
noninvasive diagnostic procedure of choice for the preop-
erative evaluation of stenoses involving the extracranial
ICA.4-6,8 In experienced centers duplex ultrasound scan-
ning is highly sensitive and specific, making it preferable as
a screening test in patients with suspected extracranial
carotid artery occlusive disease. This popularity has resulted
in a steady expansion and proliferation of noninvasive vas-
cular laboratories, from primarily hospital-based facilities to
freestanding diagnostic centers, private medical offices, and
mobile diagnostic units. In this context of an expanding
market for noninvasive vascular testing, an unfortunate
result may be that economic considerations and the wide-
spread availability of noninvasive vascular technology have
become important engines driving the proliferation. In
such an economic environment there exists the risk that
cost-effectiveness, diagnostic accuracy, and clinical efficacy
may decline, to the detriment of clinical outcome and
overall quality of patient care. In response to such increas-
ing concerns, the ICAVL was established in 1990, with the
mission of providing a peer review mechanism to ensure
high-quality patient care by setting appropriate standards
for noninvasive vascular testing.
The evidence supporting CEA for the treatment of
extracranial ICA occlusive disease is based on the degree of
stenosis as determined at carotid arteriography. Given the
increasingly widespread clinical acceptance of the results of
carotid duplex ultrasound scanning as a sole preoperative
diagnostic study, it is absolutely essential that surgical de-
cision-making be based on findings of noninvasive studies
performed with accurate technique and on appropriate
interpretation with validated criteria. Technical factors
leading to inaccurate results include poor patient position-
ing, inappropriate transducer selection, poor optimization
of instrument gain and display settings, and, likely most
important, incorrect spectral Doppler technique when
measuring blood flow velocity. In this study technical er-
rors resulted in a clinically significant inaccurate velocity
estimation in 24 arteries, 19% of the vessels with significant
discordance.
Anatomic factors such as severe calcification, anomalies
such as kinks or coils in the ICA, and contralateral ICA
occlusion may produce flow disturbances, leading to errors
in Doppler scanning velocity analysis. Abou-Zamzam et
al16 reported that contralateral carotid artery stenosis can
have a significant effect on ipsilateral ICA flow velocity,
leading to the inaccurate impression of significant stenosis.
In this study lack of recognition of one or more of these
factors in a small number of patients also was noted to lead
to overestimation of the severity of disease present.
In addition to technical factors, improper interpreta-
tion of the data obtained and the use of velocity criteria that
were not validated with a quality assurance mechanism led
to significantly inaccurate results. Errors were noted in the
interpretation of data from 43 vessels in which B-mode
imaging data, not velocity information, were used as the
primary determinant of stenosis. The great majority of
these errors (36 arteries, 84%) resulted in significant over-
estimation of the severity of stenosis, not a surprising result
of this practice. While B-mode imaging is reliable in dem-
onstrating minimal or mild obstructive disease, as disease
severity increases the accuracy of imaging alone signifi-
cantly decreases to a sensitivity of less than 50%, and accu-
rate velocity data are required to stratify lesions.17,18 The
most frequent cause of error in the studies done in nonac-
credited vascular laboratories was the use of clinically inap-
propriate velocity criteria that had not been validated with
some mechanism of quality assurance, such as correlation
with angiography. The beneficial effect of CEA found in
the NASCET and ACAS studies was based on using the
disease-free distal ICA as the reference vessel to define
percent stenosis, not the previously used carotid bulb di-
ameter. This “new” definition of stenosis has led to a
number of published reports listing velocity criteria for
diameter reduction greater than 50%, 60%, and 70%, crite-
ria that are dramatically different, for example, from those
originally published by Langlois et al19 for which the ca-
rotid bulb was the reference vessel diameter (Table I). In
the present study there appeared to be 49 arteries in which
velocity was measured correctly but the degree of stenosis
was significantly overestimated by a nonaccredited vascular
laboratory; the velocity recorded did not even closely ap-
proximate any of the criteria in Table I or other references
JOURNAL OF VASCULAR SURGERY
February 2004368 Brown et al
for the degree of stenosis given in the final impression.
These errors in “overreading” by the nonaccredited vascu-
lar laboratories were not secondary to disagreement in
velocity data, but to lack of knowledge or understanding
regarding the accepted criteria for defining degree of ste-
nosis. These results are consistent with those reported by
Elmore et al,15 who demonstrated that more than 60% of
patients referred on the basis of findings of outside duplex
ultrasound scanning and initially classified as having high-
grade stenosis (80%-99%) were inaccurately classified.
Without having gone through the accreditation process
and meeting the mandated quality assurance standards,
nonaccredited vascular laboratories have not availed them-
selves of any mechanism of self-review that would demon-
strate the errors in interpretation.
Data from Filis et al12 suggest that clinical management
of carotid artery stenosis can be successfully based solely on
findings at carotid duplex ultrasound scanning in 97% of
patients, given that the studies were performed in their
ICAVL-accredited laboratory. The results of the present
study suggest that a similar algorithm may not be appropri-
ate for studies performed in nonaccredited vascular labora-
tories. In the present study, of the 174 patients referred for
surgical evaluation for CEA, 88 patients (51%) were found
to have less than the 60% or greater stenosis diagnosed by a
nonaccredited vascular laboratory. These patients were
spared the potential consequences of unnecessary CEA. In
an additional 19 patients with less than 60% diameter
stenosis diagnosed by a nonaccredited vascular laboratory,
a repeat study in an accredited vascular laboratory showed
greater than 60% diameter stenosis in one ICA. All 19 of
these patients underwent uncomplicated CEA, which pro-
vided them with a statistically significant chance of decreas-
ing their risk for stroke, an opportunity these patients likely
would not have had if carotid duplex ultrasound scanning
had not been repeated and the degree of stenosis accurately
determined.
In light of these findings we have adopted a policy to
repeat all carotid duplex ultrasound scanning that has been
performed by a nonaccredited laboratory. However, the
inaccuracies of vascular laboratories that are not accredited
then also lead to a financial dilemma. With the data pro-
vided by Axelrod et al20 for this study in a single institution
over 2 years, an additional $32,190 was spent to repeat
carotid duplex ultrasound scanning in these patients. Pro-
jected nationwide, these costs would easily exceed several
million dollars per year. However, most insurance carriers
will not provide reimbursement for such a repeated study,
forcing the accredited vascular laboratory to absorb this
cost. This financial burden, coupled with the increasing
number of nonaccredited practices performing carotid du-
plex ultrasound scanning, may make repeating these exam-
inations cost-prohibitive. With an inaccuracy rate of greater
than 60% for nonaccredited vascular laboratories, patients
and the physicians to whom they are referred may be put in
the position of using more costly confirmatory studies such
as MRA or cerebral angiography.
In conclusion, carotid duplex ultrasound scanning has
become the sole preoperative diagnostic study in an in-
creasing number of patients before CEA. The noninvasive
nature and diagnostic accuracy of carotid duplex ultra-
sound scanning, when performed in an ICAVL-accredited
vascular laboratory, would seem to justify this practice
paradigm in a substantial majority of patients. On the other
hand, the results of this study suggest that interpretation of
carotid duplex ultrasound scans by nonaccredited vascular
laboratories should be considered with extreme caution.
Our results demonstrate that inaccurate determination of
the degree of stenosis by nonaccredited vascular laborato-
ries may adversely affect patient management and surgical
decision-making in approximately 60% of patients. The
necessity of having to repeat these studies produces an
unnecessary strain on financial resources, and, if confirmed
prospectively in larger series, the results of this preliminary
study raise the important question of whether the contin-
ued reimbursement of studies performed in nonaccredited
vascular laboratories is justified.
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DISCUSSION
Dr Enrico Ascher (Brooklyn, NY). I rise to congratulate the
authors for a timely study that reproduces what many of us have
noted in our practices.
Dr. Brown, just for clarification, are the non-ICAVL-accred-
ited laboratories also not accredited by the American College of
Radiologists or the American Institute of Ultrasound in Medicine?
While I agree with most of your conclusions, I believe that, to be
even more persuasive, your study should have included a compar-
ison of results with another ICAVL-accredited laboratory.
In your protocol, and also in ours, we included routine in-
sonation of the vertebral arteries. Could you comment on the value
of this approach, since in our experience we have found very little
value for this approach. Because of the dramatic improvement in
the quality of B-mode imaging, we now rely more and more on
these measurements than on velocities. It is possible that some of
the discrepant results in your study may have been caused by
differences between hemodynamic and B-mode imaging results.
As you know, low peak systolic velocities can be reflective of long
99% stenosis in the ICA, and high peak systolic velocities can be
created by vessel tortuosity. Since oscillations in systemic blood
pressures and cardiac output can influence velocity measurements,
could these have accounted in part for the differences in results?
Dr. Brown, many of us will not operate routinely on 60%
stenoses. Could you tell us about the accuracy of outside labora-
tories for carotid lesions causing 80% or greater stenosis.
Last, what’s your protocol to detect pseudoaneurysms of the
ICA?
I enjoyed reading the manuscript and listening to your pre-
sentation.
Dr O. William Brown. Thank you very much for your
comments, Dr. Ascher. Let me try to go through these one at a
time here, if I can.
As far as the other accreditations, I do not know whether the
other laboratories were or were not accredited by other organiza-
tions.
As for the vertebral arteries, we agree that evaluation of the
vertebral arteries probably does not provide additional information
in asymptomatic patients. However, evaluation of the vertebral
arteries may be very beneficial in patients who have nonhemi-
spheric or atypical cerebral symptoms. Therefore we continue to
include vertebral artery evaluation as part of our protocol.
As you know, the problem with using B-mode imaging tech-
niques is that the degree of stenosis tends to be overestimated by
individuals who are not familiar with looking at these types of
images.
We, too, do not operate on all patients with greater than 60%
stenosis. However, 60% was felt to be the most consistent end
point, as opposed to attempting to factor in each individual sur-
geon’s philosophies.
I, unfortunately, can’t tell you exactly how many were 80% to
90%. In some of the reports that we reviewed the stenosis read from
50% to 90%, 70% to 85%, making a breakdown of the number of
80% to 90% lesions impossible.
Dr R. Eugene Zierler (Seattle, Wash). I am serving as one of
the AAVS representatives to the ICAVL board, and I am also the
current president of the ICAVL, so nobody in this room is more
pleased with the results of your study than I am. However, I do
have some concerns. If I understand correctly, you actually looked
at one nonaccredited lab and one accredited lab. So I would ask
how generalizable you think your conclusions may be with regard
to a larger number of labs? That’s my first question.
My second comment and question concerns the qualifications
of the technologist or sonographer. You tended to focus on the
interpreting physicians, and you were unable to tell us whether the
nonaccredited lab had credentialed sonographers. In many re-
gions, the third-party payers now require either credentialed
sonographers or an accredited lab in order to qualify for reimburse-
ment. Therefore you may find that you could get reimbursed for
your repeat studies if the lab that performed the initial study did
not meet either of these criteria.
Dr Brown. As for your first question, there were multiple
nonaccredited laboratories. These were nonaccredited laboratories
from several areas. There was only one accredited laboratory.
Obviously, in a retrospective preliminary study such as this
one, I’m not sure just how generalizable our findings will be.
However, like others, we found this to be a continuing problem.
Dr Munier Nazzal (Toledo, Ohio). Dr. Brown, I have two
questions.
The first one: Most probably you based your interpretation of
other hospitals or labs on written reports. Did you look at films,
videotapes, or the whole study, or not?
The second question: Your version of interpretation and
theirs, what they were compared with, is it angiogram or just your
interpretation?
Dr Brown. We did not review the actual studies. Some of the
nonaccredited laboratories are unwilling to provide their studies
for review.
We used our ICAVL lab as baseline.
Dr Daniel J. Reddy (Detroit, Mich). We have had a parallel
experience with other labs within our own system. In our practice
a primary care doctor, for example, may have sent the patient to a
more conveniently located lab and then referred the patient to us
for study confirmation and advice. What we notice about the first
test is that, along with the occasional misinterpretation is an often
inappropriate suggestion to get an altogether different study, such
as an arteriogram. How often in your study did the initial screening
lab study result carry with it advice to get an arteriogram or other
study that may have been avoided by a diagnostic quality rather
than screening quality study?
Dr Brown. Most of the time the outside laboratories do
suggest that angiography be performed in any patient with even a
minor degree of stenosis.
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Dr Gregory L. Moneta (Portland, Ore). We need to move
away from this concept of identifying a specific level of stenosis.
Every individual and every combination of duplex-derived flow
parameters is associated with a different combination of sensi-
tivity and specificity for identifying or excluding the presence of
a specified level of angiographic stenosis. Every combination of
sensitivity and specificity is associated with different positive and
negative predictive values. When the intention is to identify
patients for a possible prophylactic operation and the therapeu-
tic index of the operation is narrow, as it is for endarterectomy
for asymptomatic carotid stenosis, you don’t want to have
parameters that just identify a level of stenosis with high sensi-
tivity; you also want to be able to identify that category of
stenosis with a very high positive predictive value. So my
question is, what positive predictive value was associated with
your criteria for a 60% lesion?
Dr Brown. I think that our predictive value, in that case, was
97% or 98% predictive value.
INVITED COMMENTARY
R. Eugene Zierler, MD, Seattle, Wash
The primary conclusion of this study by Brown et al— that the
results of carotid duplex scanning performed in non-accredited
vascular laboratories are less reliable than those from Intersocietal
Commission for the Accreditation of Vascular Laboratories (ICA-
VL)–accredited laboratories—should not surprise anyone who has
taken on the arduous task of accrediting their own laboratory. But
what does accreditation mean? Laboratories that have successfully
completed the ICAVL accreditation process in one or more of the
five testing areas are in compliance with a comprehensive set of
standards that have been set by a multidisciplinary commission of
physicians and sonographers. These standards cover all aspects of
vascular laboratory practice, from instrumentation, testing proto-
cols, interpretation criteria, and reporting to the experience and
training of personnel and quality assurance programs. Ongoing
compliance with ICAVL standards is documented with periodic
reaccreditation, including relevant continuing education for both
medical and technical staff.
While the results reported here are intuitively satisfying and
clear, the study has some limitations that must be acknowledged.
First, the study was retrospective and based solely on the content of
the final reports from the non-accredited laboratories. Original
B-mode or color-flow images and Doppler waveforms were not
available; therefore it is not possible to critically assess how the tests
were actually performed. In addition, the qualifications of the
sonographers and physicians in the non-accredited laboratories
were not known. Finally, the study involved a large number of
non-accredited laboratories, but only a few accredited laboratories.
Consequently there are a multitude of variables that may account
for the observed differences in outcome, many of which are linked
in some way to laboratory accreditation.
Carotid scanning is the most standardized and straightforward
duplex examination performed in the vascular laboratory. If the
conclusions of this study are accepted, it would be reasonable to
assume that similar (or even more extreme) differences between
non-accredited and accredited laboratories would be found for the
other applications of duplex ultrasound scanning. Physicians and
patients, who are the “consumers” of vascular laboratory services,
are entitled to some assurance that accurate and reliable testing is
being performed. Accreditation of laboratories and credentialing
of sonographers are two mechanisms for demonstrating that diag-
nostic testing is being done in a manner that meets at least
minimum standards. The value of these processes is supported in
that an increasing number of states (about 26, at this writing) have
linked payment for vascular laboratory testing to either accredita-
tion or credentialing. This report by Brown et al should serve to
focus attention on the issue of accreditation and strengthen this
trend.
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